References
- American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics. 1999;103(4 Pt 1):843–52. Erratum in: 2000;105(1 Pt 1):141. 1999;103(5 Pt 1):1052, 1999;104(1 Pt 1):118.
- Marild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr. 1998;87(5):549–52.
- Aranda JV, Cohen S, Neims AH. Drug utilization in a newborn intensive care unit. J Pediatr. 1976;89(2):315–7.
- Panaretto K, Craig J, Night J, Howman-Giles R, Sureshkumar P, Roy L. Risk factors for recurrent urinary tract infection in preschool children. J Paediatr Child Health. 1999;35(5):454–9.
- Kearns GL, Young RA. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young. Diagn Microbiol Infect Dis. 1995;22(1–2):97–104.
- Kearns GL, Young RA, Jacobs RF. Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval. Clin Pharmacokinet 1992;22(4):284–97.
- Kearns GL, Jacobs RF, Thomas BR, Darville TL, Trang JM. Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates. J Pediatr. 1989;114(3):461–7.
- Capparelli E, Hochwald C, Rasmussen M, Parham A, Bradley J, Moya F. Population pharmacokinetics of cefepime in the neonate. Antimicrob Agents Chemother. 2005;49(7):2760–6.
- Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999;104(1 Pt 1):79–8.
- Baker PC, Nelson DS, Schunk JE. The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections. Arch Pediatr Adolesc Med. 2001;155(2):135–9.
- Dayan PS, Hanson E, Bennett JE, Langsam D, Miller SZ. Clinical course of urinary tract infections in infants younger than 60 days of age. Pediatr Emerg Care. 2004;20(2):85–8.
- Gaspari RJ, Dickson E, Karlowsky J, Doern G. Antibiotic resistance trends in paediatric uropathogens. Int J Antimicrob Agents. 2005;26(4):267–71.
- Fanos V, Khoory BJ. Antimicrobial survey of urinary tract isolates from a pediatric department. J Chemother. 1999;11(4):255–9.
- Keren R, Chan E. A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children. Pediatrics. 2002;109(5):E70–0.
- Wheeler D, Vimalachandra D, Hodson EM, et al. Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child. 2003;88(8):688–94.
- Williams GJ, Lee A, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. 2001; (4): CD001534.